Opioids

Discussions Файлы Изображения Videos Ссылки Мероприятия Обмен знаниями Все

Source: Chhatwal J, Mueller PP, Chen Q, et al. Estimated Reductions in Opioid Overdose Deaths With Sustainment of Public Health Interventions in 4 US States. JAMA Netw Open. 2023;6(6):e2314925. doi:10.1001/jamanetworkopen.2023.14925 Key Points Question What is the association of sustaining public...

Estimated Reductions in Opioid Overdose Deaths With Sustainment of Public Health Interventions in 4 US States.pdf

Fuente: https://nida.nih.gov/es/download/20630/el-fentanilo-drugfacts.pdf El fentanilo es un fuerte opioide sintético similar a la morfina, pero entre 50 y 100 veces más potente. Es un fármaco recetado que a veces también se usa en forma ilegal. Al igual que la morfina, por lo general se receta a...

El fentanilo, información de NIDA.pdf

Source: National Institute on Drug Abuse; National Institutes of Health; U.S. Department of Health and Human Services. Fentanyl is a powerful synthetic opioid that is similar to morphine but is 50 to 100 times more potent. It is a prescription drug that is also made and used illegally. Like morphine...

fentanyl drugfacts NIDA.pdf

Source: Snowdon, J., & Choi, N. (2022). Unanticipated Changes in Drug Overdose Death Rates in Canada During the Opioid Crisis. International journal of mental health and addiction, 1–19. Advance online publication. https://doi.org/10.1007/s11469-022-00932-9

Unanticipated Changes in Drug Overdose Death Rates in Canada During the Opioid Crisis_0.pdf

Source: Marel, C., Wilson, J., Darke, S., Ross, J., Slade, T., Haber, P. S., Haasnoot, K., Visontay, R., Keaveny, M., Tremonti, C., Mills, K. L., & Teesson, M. (2023). Patterns and Predictors of Heroin Use, Remission, and Psychiatric Health Among People with Heroin Dependence: Key Findings from the...

Patterns and Predictors of Heroin Use, Remission, and Psychiatric Health Among People with Heroin Dependence - Key Findings from the 18-20-Year Follow-Up of the Australian Treatment Outcome Study (ATOS)_1.pdf

Fuente: https://www.fda.gov/news-events/press-announcements/la-fda-aprueba-una-nueva-opcion-de-tratamiento-con-buprenorfina-para-el-trastorno-por-consumo-de

Para publicación inmediata: 24 de mayo del 2023

Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) aprobó la inyección subcutánea (para uso por debajo de la piel) de Brixadi (buprenorfina) de liberación prolongada para tratar el trastorno por consumo de opioides (OUD, por sus siglas en inglés) de moderado a grave. Brixadi está disponible en dos formulaciones, una inyección semanal...

Source: https://www.fda.gov/news-events/press-announcements/fda-approves-new-buprenorphine-treatment-option-opioid-use-disorder

For Immediate Release: May 23, 2023

Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD). Brixadi is available in two formulations, a weekly injection that can be used in patients who have started treatment with a single dose of a transmucosal buprenorphine product or who are already being treated with buprenorphine, and...

Source: https://store.samhsa.gov/sites/default/files/pep23-02-01-002.pdf This Advisory outlines how healthcare providers (i.e., obstetrician-gynecologists [OB-GYNs], primary care physicians, and other professionals who treat pregnant people) can take an active role in supporting the health of...

Advisory Evidence-Based, Whole Person Care of Pregnant People Who Have Opioid Use Disorder_1.pdf

Source: Taylor EA, Cantor JH, Bradford AC, Simon K, Stein BD. Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes. JAMA Netw Open. 2023;6(5):e2314328. doi:10.1001/jamanetworkopen.2023.14328 Key Points Question Did rates of methadone dispensing for opioid use...

Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes_0.pdf

Source: Jakubowski, A., Singh-Tan, S., Torres-Lockhart, K. et al. Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation. Addict Sci Clin Pract 18, 31 (2023). https://doi.org/10.1186/s13722-023-00386-x Abstract...

Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder opportunities for training innovation_0.pdf

Format

Наборы инструментов

Published by / Citation

Degenhardt, L., Clark, B., Macpherson, G., Leppan, O., Nielsen, S., Zahra, E., ... & Farrell, M. (2023). Buprenorphine versus methadone for the of opioid dependence: a systematic review and meta-analysis of randomised and observational studies. The Lancet Psychiatry.

Сводка

Фон

Опиоидная зависимость связана со значительным бременем для здоровья и общества, и лечение опиоидными агонистами (ОАТ) является высокоэффективным для улучшения множественных исходов у людей, получающих это лечение. Метадон и бупренорфин являются распространенными лекарствами, назначаемыми в виде ОАТ. Мы стремились изучить бупренорфин в сравнении с метадоном в лечении опиоидной зависимости по широкому спектру первичных и вторичных исходов.

Методика

Авторы провели систематический обзор и мета-анализ исследований, в которых сравнивали лечение бупренорфином или метадоном. Первичными...

Source: Onuoha, E. N., Leff, J. A., Schackman, B. R., McCollister, K. E., Polsky, D., & Murphy, S. M. (2021). Economic evaluations of pharmacologic treatment for opioid use disorder: a systematic literature review. Value in Health, 24(7), 1068-1083. Highlights There is new evidence on buprenorphine...

Click here → to read the full text

Ponente: Dr. Carlos Galicia Galicia Los objetivos del seminario son conocer el fentanilo de uso médico y diferenciarlo del producido clandestinamente. Además, presentar los fundamentos neurobiológicos del consumo compulsivo de fentanilo.

Source: Hooker, S. A., Crain, A. L., LaFrance, A. B., Kane, S., Fokuo, J. K., Bart, G., & Rossom, R. C. (2023). A randomized controlled trial of an intervention to reduce stigma toward people with opioid use disorder among primary care clinicians. Addiction Science & Clinical Practice, 18(1), 1-10...

A randomized controlled trial of an intervention to reduce stigma toward people with opioid use disorder among primary care clinicians_0.pdf

Format

Книги

Published by / Citation

Mid-America ATTC (MATTC)

Среднеамериканский центр передачи технологий лечения зависимостей (MATTC) в партнерстве с Сетью реагирования на опиоиды этнических сообществ в Миссури, Форумом по политике в отношении наркомании и Сетью реагирования на опиоиды (ORN в штатах Айова, Канзас, Миссури и Небраска) перевели 5 различных научно обоснованных профилактических продуктов «Образовательные материалы по профилактике употребления опиоидов» на 12 различных языков, и обеспечить их соответствие культурным особенностям, включая арабский, боснийский, бирманский, дари, французский, мандаринский диалект китайского языка, пушту...

Upcoming Events

There aren't any upcoming events

All Events

Estimated Reductions in Opioid Overdose Deaths With Sustainment of Public Health Interventions in 4 US States

El fentanilo, información de NIDA

Fentanyl DrugFacts

Unanticipated Changes in Drug Overdose Death Rates in Canada During the Opioid Crisis.

Patterns and Predictors of Heroin Use, Remission, and Psychiatric Health Among People with Heroin Dependence: Key Findings from the 18-20-Year Follow-Up of the Australian Treatment Outcome Study (ATOS).

La FDA aprueba una nueva opción de tratamiento con buprenorfina para el trastorno por consumo de opioides

FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder

Advisory: Evidence-Based, Whole Person Care of Pregnant People Who Have Opioid Use Disorder

Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes

Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation

Сводка

Economic Evaluations of Pharmacologic Treatment for Opioid Use Disorder: A Systematic Literature Review

Цели и задачи Международной научной конференции

Fentanilo, de lo Molecular a lo Social - Dr. Carlos Galicia Galicia

A randomized controlled trial of an intervention to reduce stigma toward people with opioid use disorder among primary care clinicians

Upcoming Events